| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Avidity assay to test functionality of anti-SARS-Cov-2 antibodies
|
Gaspar, Emanuelle Baldo
|
|
|
39 |
10 |
p. 1473-1475
|
artikel
|
| 2 |
Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial
|
Abu-Elyazeed, Remon
|
|
|
39 |
10 |
p. 1534-1543
|
artikel
|
| 3 |
Corrigendum to “Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance” [Vaccine 38(43) (2020) 6757–6765]
|
Bruce-Staskal, Pamela J.
|
|
|
39 |
10 |
p. 1544-1545
|
artikel
|
| 4 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
10 |
p. IFC
|
artikel
|
| 5 |
Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia
|
Lin, Jialing
|
|
|
39 |
10 |
p. 1493-1498
|
artikel
|
| 6 |
Effects of measles-containing vaccination in children with severe underlying neurologic disease
|
Dimopoulou, Dimitra
|
|
|
39 |
10 |
p. 1481-1484
|
artikel
|
| 7 |
Formative research to address vaccine hesitancy in Tajikistan
|
Klassen, Ann Carroll
|
|
|
39 |
10 |
p. 1516-1527
|
artikel
|
| 8 |
General determination of causation between Covid-19 vaccines and possible adverse events
|
Hampton, Lee M.
|
|
|
39 |
10 |
p. 1478-1480
|
artikel
|
| 9 |
Humoral immune response to Q fever vaccination of three sheep flocks naturally pre-infected with Coxiella burnetii
|
Bauer, Benjamin U.
|
|
|
39 |
10 |
p. 1499-1507
|
artikel
|
| 10 |
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age
|
Ward, Brian J.
|
|
|
39 |
10 |
p. 1528-1533
|
artikel
|
| 11 |
Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017
|
Khetsuriani, Nino
|
|
|
39 |
10 |
p. 1485-1492
|
artikel
|
| 12 |
Social amplification of risk and “probable vaccine damage”: A typology of vaccination beliefs in 28 European countries
|
Vulpe, Simona - Nicoleta
|
|
|
39 |
10 |
p. 1508-1515
|
artikel
|
| 13 |
Why not the ‘marker’ or DIVA vaccines for the control of emerging infectious diseases of humans?
|
Singh, Ajit
|
|
|
39 |
10 |
p. 1476-1477
|
artikel
|
Tijdschrift beschrijving